Financials
- Market Capitalization 10.59 M
- Employee 39
- Founded 2016
- CEO N/A
- Website www.sentibio.com
- Headquarter Delaware, United States
- FIGI BBG021Y8RQQ5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4726 | CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.55 USD | +1.31% | +10.71% | -11.43% | +5.08% | 11.15 M USD | ||
| 4732 | GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.93 USD | -6.06% | -2.11% | -1.06% | -46.86% | 11.00 M USD | ||
| 4744 | GTBP GT Biopharma, Inc. - Common Stock | 0.29 USD | -6.45% | -12.12% | -42.00% | -82.94% | 10.46 M USD | ||
| 4749 | INAB IN8bio, Inc. - Common Stock | 1.04 USD | -3.70% | -15.45% | -28.77% | -37.72% | 10.24 M USD |
Frequently asked questions about Senti Biosciences, Inc. - Common Stock
What is the Senti Biosciences, Inc. - Common Stock stock price today?
The current price of Senti Biosciences, Inc. - Common Stock (SNTI) is 0.34. Over the past 24 hours, the stock has changed by -5.56%. Follow the SNTI chart for real-time price dynamics.
What is the stock ticker of Senti Biosciences, Inc. - Common Stock?
Senti Biosciences, Inc. - Common Stock trades under the ticker SNTI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Senti Biosciences, Inc. - Common Stock stock going up?
SNTI has changed by -15.00% over the last week, -68.52% over the last month, and -64.29% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Senti Biosciences, Inc. - Common Stock?
Senti Biosciences, Inc. - Common Stock currently has a market capitalization of 10.59 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Senti Biosciences, Inc. - Common Stock earnings last quarter?
Last quarter, Senti Biosciences, Inc. - Common Stock reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Senti Biosciences, Inc. - Common Stock revenue for the last quarter?
Senti Biosciences, Inc. - Common Stock reported quarterly revenue of 16 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Senti Biosciences, Inc. - Common Stock net income for the last quarter?
Senti Biosciences, Inc. - Common Stock reported net income of -4.22 M for the last quarter. The previous quarter showed -14.47 M, which means net income changed by +70.82%.
How many employees does Senti Biosciences, Inc. - Common Stock have?
As of the latest available data, Senti Biosciences, Inc. - Common Stock has 39 employees. Workforce size can provide additional context about the company's scale and operations.
What is Senti Biosciences, Inc. - Common Stock EBITDA?
Senti Biosciences, Inc. - Common Stock EBITDA is -3.93 M, and its EBITDA margin is -24.55 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Senti Biosciences, Inc. - Common Stock stock?
You can buy Senti Biosciences, Inc. - Common Stock (SNTI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Senti Biosciences, Inc. - Common Stock stock?
Investing in Senti Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SNTI chart and related analysis on metatrader.com as part of your research.